• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 78 of 100
Apple Starts iPhone 6 Sales In Germany
TechA New Smartphone App Promises Help for Schizophrenia
By David Z. MorrisApril 9, 2016
Stocks Continue Downward Slide On Heels Of Yesterday's Extreme Fall
FinanceIntercept Pharma’s Shares Spike Before Falling On Key FDA Panel Backing
By Sy MukherjeeApril 8, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
HealthAllergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed
By Sy MukherjeeApril 7, 2016
American Pharmaceutical Company Pfizer Propose To Takeover British AstraZeneca
HealthA Federal Judge Dismissed More Than 300 Lawsuits Against Pfizer
By Sy MukherjeeApril 7, 2016
Losses mount for U.S. stocks.
FinanceThis Pharma Company’s Stock Is Popping for No Clear Reason
By Sy MukherjeeApril 7, 2016
Johns Hopkins Hospital Continues Cancer Research And Treatment
HealthCancer Treatment Costs Aren’t Rising as Fast as You Thought
By Laura LorenzettiApril 6, 2016
Over 400 Marijuana Stores Ordered To Close As City Regulates Industry
RetailThe DEA Will Soon Decide Whether it Will Reschedule Marijuana
By Tom Huddleston Jr.April 6, 2016
External Insulin Pump
HealthLifesaving Diabetes Drug Price Tripled in 10 Years
By TIME and Alexandra SifferlinApril 6, 2016
Inside of a Gilead Sciences Lab
HealthThe FDA Just Approved Another Next-Gen Gilead HIV Drug
By Sy MukherjeeApril 5, 2016
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
FinanceThis Is Why Valeant’s Shares Are Soaring
By Lucinda ShenApril 5, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
HealthSex Doesn’t Sell: Valeant Cutting Its ‘Female Viagra’ Sales Force
By ReutersApril 5, 2016
DNA genetic testing (crop)
HealthGlaxoSmithKline Is One Step Closer to EU Approval for Its Gene Therapy
By Sy MukherjeeApril 4, 2016
Makers Took Big Price Increases on Widely Used U.S. Drugs
HealthMakers Took Big Price Increases on Widely Used U.S. Drugs
By ReutersApril 4, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
HealthSamsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push
By ReutersApril 4, 2016
SWITZERLAND-PHARMA-EARNINGS-COMPANY-NOVARTIS
HealthNovartis Takes Entresto Case to U.S. Cardiologist Meeting
By ReutersApril 2, 2016
1...
  • 76
  • 77
  • 78
  • 79
  • 80
...100
Most Popular
Success
Scottie Scheffler joined Tiger Woods and Rory McIlroy in golf's $100M club—and donated his entire Ryder Cup stipend to charityplaceholder alt text
By Fortune EditorsApril 10, 2026
Innovation
Schools across America are quietly admitting that screens in classrooms made students worse off and are reversing years of tech-first policiesplaceholder alt text
By Fortune EditorsApril 10, 2026
Investing
Mark Cuban admits he made a mistake letting go of the Mavericks: 'I don't regret selling. I regret who I sold to'placeholder alt text
By Fortune EditorsApril 9, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.